Proton surgery zaps early lung tumors in first human test
NCT ID NCT07195084
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early study tests a new type of radiation surgery called hypervision proton surgery for people with early-stage non-small cell lung cancer. The goal is to see if a single, high-dose treatment is safe and can control the tumor. Only 12 participants will be enrolled, and researchers will monitor side effects and survival for one year.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Anhui Provincial Hospital
RECRUITINGHefei, Anhui, 230001, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new immunotherapy combo outsmart advanced lung cancer?
- Double attack on mutant KRAS: can two targeted drugs outsmart resistant cancers?
- Seeing the fight: new imaging tracer may reveal how immune cells attack lung cancer
- Could a bronchial wash detect lung cancer mutations faster?
- Can a targeted pill outsmart a tough lung cancer mutation?
- Can a PET scan reveal hidden heart harm from lung cancer treatment?